BIOHIT HealthCare is excited to be attending several of the most prestigious ENT meetings across the UK in 2024, including the National Conference ENT, ENT UK Spring Meeting, Joint ENT Scotland/ North of England Otolaryngology Society Meeting and Cutting Edge Laryngology. Representatives from the BIOHIT team will join specialists in the field to discuss cutting-edge advancements and showcase the power of Peptest, a simple lateral flow test for the diagnosis of laryngopharyngeal reflux (LPR).
Peptest is a rapid, front-line test to non-invasively assess and monitor LPR, streamlining patient care pathways. Peptest uses advanced lateral flow technology to objectively measure pepsin in clinical saliva samples collected by patients at home or in clinics, alleviating the reliance on costly and invasive diagnostic assessments to significantly improve patient comfort.
FURTHER INFORMATION:
Join us at one of these events or visit www.biohithealthcare.co.uk/biohit-product/peptest/ to learn more about Peptest.
